ストックスクリーナーアプリを入手
11.20
1.26%
0.1042
前日終値:
$11.10
開ける：
$11.27
24時間の取引高:
59,272
Relative Volume:
0.08
時価総額：
$335.54M
収益：
$36.97M
当期純損益:
$-25.54M
株価収益率:
-12.42
EPS:
-0.9022
ネットキャッシュフロー:
$-24.45M
1週間 パフォーマンス:
+8.70%
1か月 パフォーマンス:
+19.83%
6か月 パフォーマンス:
-38.34%
1年 パフォーマンス:
-14.26%
1日の値動き範囲:
$10.84
$11.27
1週間の範囲:
$10.26
$11.73
52週間の値動き範囲:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
名前
Clearpoint Neuro Inc
セクター
電話
(949) 900-6833
住所
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.19 | 332.84M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
87.16 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
296.20 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
78.31 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.48 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.13 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2023-10-24 | 開始されました | Stifel | Buy |
| 2023-02-16 | 再開されました | B. Riley Securities | Buy |
| 2022-04-05 | 再開されました | B. Riley Securities | Buy |
| 2021-03-18 | 開始されました | Lake Street | Buy |
| 2020-07-17 | 開始されました | B. Riley FBR | Buy |
すべてを表示
Clearpoint Neuro Inc (CLPT) 最新ニュース
Discipline and Rules-Based Execution in CLPT Response - Stock Traders Daily
ClearPoint Neuro to report first quarter 2026 results on May 13 - Traders Union
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - ACCESS Newswire
ClearPoint Neuro schedules May 13 earnings call after market close - Stock Titan
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook - Seeking Alpha
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it - MSN
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Chronicle-Tribune
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - News-Press NOW
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro | DEFA14A: Others - Moomoo
[ARS] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro completes first procedure with new drill system By Investing.com - Investing.com India
Lake Street Initiates ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint (CLPT): Buy, Sell, or Hold? | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
ClearPoint Neuro (CLPT) Achieves Milestone with New Surgical Dri - GuruFocus
ClearPoint Neuro completes first procedure with new drill system - Investing.com
ClearPoint Neuro wins FDA clearance for Velocity Alpha MR High Speed Surgical Drill System - Traders Union
ClearPoint's brain surgery drill gets FDA clearance, first clinical use - Stock Titan
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON) - The Globe and Mail
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - 富途牛牛
ClearPoint Neuro receives Canadian clearance for navigation system By Investing.com - Investing.com India
ClearPoint Neuro gets Canadian approval for navigation system - Investing.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3%Should You Sell? - MarketBeat
ClearPoint Neuro gets Canadian approval for navigation system By Investing.com - Investing.com India
ClearPoint Neuro receives Canadian clearance for navigation system - Investing.com
ClearPoint Neuro (CLPT) Receives Medical Device License from Hea - GuruFocus
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug De - PharmiWeb.com
Bigger Capital Group (CLPT) files ownership update showing 7.54% attributed to Michael Bigger - Stock Titan
Canadian regulators clear ClearPoint Neuro navigation system, expanding device reach - Traders Union
Canada clears ClearPoint brain navigation system for clinical trial sites - Stock Titan
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint | FinancialContent - FinancialContent
(CLPT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Clearpoint Neuro Inc (CLPT) 財務データ
収益
当期純利益
現金流量
EPS
0.76%
0.72%
大文字化:
|
ボリューム (24 時間):